163 studies on IL-6 mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
BPC 157's ability to rapidly reduce intra-abdominal pressure, mitigate inflammation, and improve organ perfusion suggests a novel and highly promising therapeutic strategy for Abdominal Compartment Syndrome. This stud…
This research strongly positions BPC 157 as a highly promising therapeutic candidate for preventing and treating radiation-induced liver injury, offering a novel mechanism through the upregulation of Kruppel-like fact…
This research highlights the significant potential of BPC 157 as a powerful protective agent against the severe adverse effects associated with antiarrhythmic drugs like Sotalol and in conditions involving impaired bl…
This study provides compelling evidence that BPC 157 effectively protects against severe organ damage and significantly improves recovery following intra-abdominal hypertension and subsequent reperfusion injury. The o…
This comprehensive review highlights BPC 157's robust potential as a therapeutic agent for improving outcomes in gastrointestinal surgery. Its ability to enhance tissue repair, strengthen surgical connections, and red…
This research highlights the multifaceted therapeutic potential of BPC 157 in critical conditions like ACS and IAH, which currently have limited pharmacological options. Its ability to reduce compartment pressure, enh…
This discussion reinforces the robust evidence supporting BPC-157 as a potent cytoprotective and regenerative agent, particularly for gastrointestinal health. The consistent findings across numerous preclinical studie…
This research highlights the significant therapeutic potential of N-Acetylcysteine and especially Elamipretide (SS-31) as interventions for ozone-induced respiratory injury. Given that Elamipretide specifically target…
This study provides compelling evidence that GHRP-6 holds significant therapeutic potential for both the acute phase of lung injury and the chronic development of interstitial fibrosis. The ability of GHRP-6 to simult…
This study presents a highly promising and innovative therapeutic strategy for Ulcerative Colitis by directly targeting mucosal barrier dysfunction. The temperature-sensitive nature of the hydrogel allows for easy adm…
This comprehensive review highlights the significant therapeutic potential of tripeptides as a novel class of agents for treating chronic wounds and skin injuries. Their multi-faceted mechanisms of action, including a…
This study provides compelling evidence that targeting epithelial cell activation with EpithelioModulin-1 (EM-1) can effectively mitigate both local glandular inflammation and systemic autoimmunity in a preclinical mo…
This study provides compelling evidence that a combination of IL-15 and Thymosin α1 can effectively target and reduce senescent hepatic CD8+ T cells, offering a novel therapeutic strategy for chronic liver diseases an…